Merck & Co. Equity securities decreased by 10.0% to $1.39B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 51.3%, from $920.00M to $1.39B. Over 5 years (FY 2020 to FY 2025), Equity securities shows a downward trend with a -4.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Growth indicates successful stock selection or market rallies, while declines reflect market downturns or divestments.
The total market value of the company's ownership interests in publicly traded corporations. This portfolio is a primary...
Peer insurance firms often hold more fixed-income assets; a high concentration here signals a more aggressive, total-return investment philosophy.
ins_equity_securities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.58B | $1.92B | $1.65B | $1.40B | $1.53B | $1.33B | $1.28B | $1.59B | $1.52B | $1.75B | $764.00M | $908.00M | $1.03B | $984.00M | $920.00M | $1.03B | $1.18B | $1.55B | $1.39B |
| QoQ Change | — | +21.3% | -14.0% | -15.2% | +9.5% | -12.8% | -3.7% | +23.4% | -4.1% | +14.9% | -56.2% | +18.8% | +13.0% | -4.1% | -6.5% | +12.3% | +14.3% | +30.9% | -10.0% |
| YoY Change | — | — | — | — | -3.1% | -30.3% | -22.0% | +13.5% | -0.7% | +30.9% | -40.5% | -42.7% | -32.5% | -43.6% | +20.4% | +13.8% | +15.1% | +57.1% | +51.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.